News BIO rings alarm bells over Trump's pharma tariffs US tariffs on goods coming from Europe, China, and Canada could have a major impact on the biopharma industry and medicines access, says BIO.
News AZ builds in China, as J&J ramps up its US investments AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.
R&D Building a regenerative medicine industry: Lessons from Nort... The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions.
News EU proposes legislation to bolster medicines supply chain The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.
News MSD opens $1bn plant for HPV vaccine in the US MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.
News Lilly unveils $27bn reshoring drive around four new plants Trump threatened tariffs if businesses do not reshore production to the US - and Lilly has now revealed a $27bn spend on new domestic facilities.
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.